Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1185656

Oxidative Stress and Cancer Heterogeneity Orchestrate NRF2 Roles Relevant for Therapy Response


Gall Trošelj, Koraljka; Tomljanović, Marko; Jaganjac, Morana; Matijević Glavan, Tanja; Čipak Gašparović, Ana; Milković , Lidija; Borović Šunjić, Suzana; Buttari, Brigitta; Profumo, Elisabetta; Saha, Sarmistha et al.
Oxidative Stress and Cancer Heterogeneity Orchestrate NRF2 Roles Relevant for Therapy Response // Molecules, 27 (2022), 5; 1468-1495 doi:10.3390/molecules27051468 (međunarodna recenzija, pregledni rad, znanstveni)


CROSBI ID: 1185656 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Oxidative Stress and Cancer Heterogeneity Orchestrate NRF2 Roles Relevant for Therapy Response

Autori
Gall Trošelj, Koraljka ; Tomljanović, Marko ; Jaganjac, Morana ; Matijević Glavan, Tanja ; Čipak Gašparović, Ana ; Milković , Lidija ; Borović Šunjić, Suzana ; Buttari, Brigitta ; Profumo, Elisabetta ; Saha, Sarmistha ; Saso, Luciano ; Žarković, Neven

Izvornik
Molecules (1420-3049) 27 (2022), 5; 1468-1495

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni

Ključne riječi
4-hydroxynonenal ; therapy resistance ; cancer stem cells ; tumor associated macrophages (TAMs) ; tumor associated neutrophils (TANs) ; polarization ; NFE2L2 promoter ; KEAP-1 ; micro RNA

Sažetak
Oxidative stress and its end-products, such as 4- hydroxynonenal (HNE), initiate activation of the Nuclear Factor Erythroid 2-Related Factor 2 (NRF2)/Kelch Like ECH Associated Protein 1 (KEAP1) signaling pathway that plays a crucial role in the maintenance of cellular redox homeostasis. However, an involvement of 4-HNE and NRF2 in processes associated with the initiation of cancer, its progression, and response to therapy includes numerous, highly complex events. They occur through interactions between cancer and stromal cells. These events are dependent on many cell-type specific features. They start with the extent of NRF2 binding to its cytoplasmic repressor, KEAP1, and extend to the permissiveness of chromatin for transcription of Antioxidant Response Element (ARE)- containing genes that are NRF2 targets. This review will explore epigenetic molecular mechanisms of NRF2 transcription through the specific molecular anatomy of its promoter. It will explain the role of NRF2 in cancer stem cells, with respect to cancer therapy resistance. Additionally, it also discusses NRF2 involvement at the cross-roads of communication between tumor associated inflammatory and stromal cells, which is also an important factor involved in the response to therapy.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Projekti:
HRZZ-IP-2016-06-4404 - NRF2 na raskrižju epigenetičkog modeliranja, metabolizma i proliferacije stanice raka (CrossEMPATICNRF2) (Gall-Trošelj, Koraljka, HRZZ - 2016-06) ( CroRIS)

Ustanove:
Institut "Ruđer Bošković", Zagreb

Poveznice na cjeloviti tekst rada:

doi www.mdpi.com fulir.irb.hr

Citiraj ovu publikaciju:

Gall Trošelj, Koraljka; Tomljanović, Marko; Jaganjac, Morana; Matijević Glavan, Tanja; Čipak Gašparović, Ana; Milković , Lidija; Borović Šunjić, Suzana; Buttari, Brigitta; Profumo, Elisabetta; Saha, Sarmistha et al.
Oxidative Stress and Cancer Heterogeneity Orchestrate NRF2 Roles Relevant for Therapy Response // Molecules, 27 (2022), 5; 1468-1495 doi:10.3390/molecules27051468 (međunarodna recenzija, pregledni rad, znanstveni)
Gall Trošelj, K., Tomljanović, M., Jaganjac, M., Matijević Glavan, T., Čipak Gašparović, A., Milković , L., Borović Šunjić, S., Buttari, B., Profumo, E. & Saha, S. (2022) Oxidative Stress and Cancer Heterogeneity Orchestrate NRF2 Roles Relevant for Therapy Response. Molecules, 27 (5), 1468-1495 doi:10.3390/molecules27051468.
@article{article, author = {Gall Tro\v{s}elj, Koraljka and Tomljanovi\'{c}, Marko and Jaganjac, Morana and Matijevi\'{c} Glavan, Tanja and \v{C}ipak Ga\v{s}parovi\'{c}, Ana and Milkovi\'{c}, Lidija and Borovi\'{c} \v{S}unji\'{c}, Suzana and Buttari, Brigitta and Profumo, Elisabetta and Saha, Sarmistha and Saso, Luciano and \v{Z}arkovi\'{c}, Neven}, year = {2022}, pages = {1468-1495}, DOI = {10.3390/molecules27051468}, keywords = {4-hydroxynonenal, therapy resistance, cancer stem cells, tumor associated macrophages (TAMs), tumor associated neutrophils (TANs), polarization, NFE2L2 promoter, KEAP-1, micro RNA}, journal = {Molecules}, doi = {10.3390/molecules27051468}, volume = {27}, number = {5}, issn = {1420-3049}, title = {Oxidative Stress and Cancer Heterogeneity Orchestrate NRF2 Roles Relevant for Therapy Response}, keyword = {4-hydroxynonenal, therapy resistance, cancer stem cells, tumor associated macrophages (TAMs), tumor associated neutrophils (TANs), polarization, NFE2L2 promoter, KEAP-1, micro RNA} }
@article{article, author = {Gall Tro\v{s}elj, Koraljka and Tomljanovi\'{c}, Marko and Jaganjac, Morana and Matijevi\'{c} Glavan, Tanja and \v{C}ipak Ga\v{s}parovi\'{c}, Ana and Milkovi\'{c}, Lidija and Borovi\'{c} \v{S}unji\'{c}, Suzana and Buttari, Brigitta and Profumo, Elisabetta and Saha, Sarmistha and Saso, Luciano and \v{Z}arkovi\'{c}, Neven}, year = {2022}, pages = {1468-1495}, DOI = {10.3390/molecules27051468}, keywords = {4-hydroxynonenal, therapy resistance, cancer stem cells, tumor associated macrophages (TAMs), tumor associated neutrophils (TANs), polarization, NFE2L2 promoter, KEAP-1, micro RNA}, journal = {Molecules}, doi = {10.3390/molecules27051468}, volume = {27}, number = {5}, issn = {1420-3049}, title = {Oxidative Stress and Cancer Heterogeneity Orchestrate NRF2 Roles Relevant for Therapy Response}, keyword = {4-hydroxynonenal, therapy resistance, cancer stem cells, tumor associated macrophages (TAMs), tumor associated neutrophils (TANs), polarization, NFE2L2 promoter, KEAP-1, micro RNA} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font